세계의 세포 표면 마커 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2030년)

The global demand for Cell Surface Markers Market is presumed to reach the market size of nearly USD 1549.87 MN by 2030 from USD 749.86 MN in 2022 with a CAGR of 9.5% under the study period 2023 - 2030.

Cell surface markers, also known as cell surface antigens or membrane markers, are proteins or molecules present on the outer surface of cells. These markers serve various purposes, including identification, communication, and interaction between cells, as well as being used for diagnostic and therapeutic purposes. These play a significant role in immunology, as they help distinguish different cell types and allow the immune system to recognize and respond to foreign substances or pathogens. These markers can also provide insights into the physiological state of cells, their developmental stage, and their specific functions within tissues and organs.

MARKET DYNAMICS:

Evolving cell biology and immunology research demand accurate tools to identify and analyze cell surface markers, shedding light on cell functions and interactions. Cell markers are critical for understanding immune responses and developing targeted cancer therapies, fueling demand for tools to characterize immune cells and disease subtypes. Cell markers aid disease subtype identification, aligning with personalized medicine's need for tailored treatments based on individual patient profiles. Identification of disease-associated markers drives diagnostic tests and targeted therapies, attracting interest from the biotech and pharmaceutical sectors. Improved antibody tech, imaging methods, and data analysis enhance cell marker detection and analysis capabilities. Markers guide stem cell identification and differentiation stages, which are vital for regenerative medicine applications. Industry-academia collaboration and funding injections support research and biotechnology innovations in this dynamic field.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell surface markers. The growth and trends of cell surface markers industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cell surface markers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Antibody
• PCR Array

By Source

• Mice
• Rat

By Cell Type

• T Cells
• B Cells
• NK Cell

By Application

• Research (Stem Cell, Immunology)
• Clinical (Oncology, Hematology)

By End User

• Hospitals

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cell Surface Markers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Surface Markers market include Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Becton, Dickinson and Company (US), F. Hoffman-La Roche (Switzerland), Bio-Rad Laboratories (US), Danaher Corporation (US), Abcam (UK), GenScript (China), BioLegend (US), Cell Signaling Technology (US), Marck KGaA (Germany), Bio-Techne (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CELL SURFACE MARKERS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Source
  • 3.7.3 Market Attractiveness Analysis By Cell Type
  • 3.7.4 Market Attractiveness Analysis By Application
  • 3.7.5 Market Attractiveness Analysis By End User
  • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Antibody Historic and Forecast Sales by Regions
• 5.5 PCR Array Historic and Forecast Sales by Regions

6 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY SOURCE

• 6.1 Overview by Source
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Source
• 6.4 Mice Historic and Forecast Sales by Regions
• 6.5 Rat Historic and Forecast Sales by Regions

7 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY CELL TYPE

• 7.1 Overview by Cell Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Cell Type
• 7.4 T Cells Historic and Forecast Sales by Regions
• 7.5 B Cells Historic and Forecast Sales by Regions
• 7.6 NK Cell Historic and Forecast Sales by Regions

8 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY APPLICATION

• 8.1 Overview by Application
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Application
• 8.4 Research (Stem Cell, Immunology) Historic and Forecast Sales by Regions
• 8.5 Clinical (Oncology, Hematology) Historic and Forecast Sales by Regions

9 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY END USER

• 9.1 Overview by End User
• 9.2 Historical and Forecast Data
• 9.3 Analysis by End User
• 9.4 Hospitals Historic and Forecast Sales by Regions

10 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.3.2. North America By Segment Sales Analysis
  • 10.3.3. North America By Country Sales Analysis
  • 10.3.4. United State Sales Analysis
  • 10.3.5. Canada Sales Analysis
  • 10.3.6. Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.4.2. Europe by Segment Sales Analysis
  • 10.4.3. Europe by Country Sales Analysis
  • 10.4.4. United Kingdom Sales Analysis
  • 10.4.5. France Sales Analysis
  • 10.4.6. Germany Sales Analysis
  • 10.4.7. Italy Sales Analysis
  • 10.4.8. Russia Sales Analysis
  • 10.4.9. Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.5.2. Asia Pacific by Segment Sales Analysis
  • 10.5.3. Asia Pacific by Country Sales Analysis
  • 10.5.4. China Sales Analysis
  • 10.5.5. India Sales Analysis
  • 10.5.6. Japan Sales Analysis
  • 10.5.7. South Korea Sales Analysis
  • 10.5.8. Australia Sales Analysis
  • 10.5.9. South East Asia Sales Analysis
  • 10.5.10. Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.6.2. Latin America by Segment Sales Analysis
  • 10.6.3. Latin America by Country Sales Analysis
  • 10.6.4. Brazil Sales Analysis
  • 10.6.5. Argentina Sales Analysis
  • 10.6.6. Peru Sales Analysis
  • 10.6.7. Chile Sales Analysis
  • 10.6.8. Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.7.2. Middle East & Africa by Segment Sales Analysis
  • 10.7.3. Middle East & Africa by Country Sales Analysis
  • 10.7.4. Saudi Arabia Sales Analysis
  • 10.7.5. UAE Sales Analysis
  • 10.7.6. Israel Sales Analysis
  • 10.7.7. South Africa Sales Analysis
  • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE CELL SURFACE MARKERS COMPANIES

• 11.1. Cell Surface Markers Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF CELL SURFACE MARKERS INDUSTRY

• 12.1. Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Thermo Fisher Scientific (US)
  • 12.3.1. Company Overview
  • 12.3.2. Company Revenue
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. QIAGEN N.V. (Netherlands)
  • 12.4.1. Company Overview
  • 12.4.2. Company Revenue
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. Becton
  • 12.5.1. Company Overview
  • 12.5.2. Company Revenue
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. Dickinson and Company (US)
  • 12.6.1. Company Overview
  • 12.6.2. Company Revenue
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. F. Hoffman-La Roche (Switzerland)
  • 12.7.1. Company Overview
  • 12.7.2. Company Revenue
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. Bio-Rad Laboratories (US)
  • 12.8.1. Company Overview
  • 12.8.2. Company Revenue
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. Danaher Corporation (US)
  • 12.9.1. Company Overview
  • 12.9.2. Company Revenue
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Abcam (UK)
  • 12.10.1. Company Overview
  • 12.10.2. Company Revenue
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. GenScript (China)
  • 12.11.1. Company Overview
  • 12.11.2. Company Revenue
  • 12.11.3. Products
  • 12.11.4. Recent Developments
• 12.12. BioLegend (US)
  • 12.12.1. Company Overview
  • 12.12.2. Company Revenue
  • 12.12.3. Products
  • 12.12.4. Recent Developments
• 12.13. Cell Signaling Technology (US)
  • 12.13.1. Company Overview
  • 12.13.2. Company Revenue
  • 12.13.3. Products
  • 12.13.4. Recent Developments
• 12.14. Marck KGaA (Germany)
  • 12.14.1. Company Overview
  • 12.14.2. Company Revenue
  • 12.14.3. Products
  • 12.14.4. Recent Developments
• 12.15. Bio-Techne (US)
  • 12.15.1. Company Overview
  • 12.15.2. Company Revenue
  • 12.15.3. Products
  • 12.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies